These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 1748548

  • 1. Retinal polyol and myo-inositol in galactosemic dogs given an aldose-reductase inhibitor.
    Kern TS, Engerman RL.
    Invest Ophthalmol Vis Sci; 1991 Dec; 32(13):3175-7. PubMed ID: 1748548
    [Abstract] [Full Text] [Related]

  • 2. Galactose-induced retinal microangiopathy in rats.
    Kern TS, Engerman RL.
    Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):490-6. PubMed ID: 7843917
    [Abstract] [Full Text] [Related]

  • 3. Aldose reductase inhibition fails to prevent retinopathy in diabetic and galactosemic dogs.
    Engerman RL, Kern TS.
    Diabetes; 1993 Jun; 42(6):820-5. PubMed ID: 8495805
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Osmoregulatory alterations in myo-inositol uptake by bovine lens epithelial cells. Part 1: A hypertonicity-induced protein enhances myo-inositol transport.
    Cammarata PR, Chen HQ.
    Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):1223-35. PubMed ID: 8125733
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Capillary basement membrane in retina, kidney, and muscle of diabetic dogs and galactosemic dogs and its response to 5 years aldose reductase inhibition.
    Engerman RL, Kern TS, Garment MB.
    J Diabetes Complications; 1993 Mar; 7(4):241-5. PubMed ID: 8219367
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the effects of Zopolrestat and Sorbinil on lens myo-inositol influx.
    Beyer-Mears A, Diecke FP, Mistry K, Cruz E.
    Pharmacology; 1997 Feb; 54(2):76-83. PubMed ID: 9088040
    [Abstract] [Full Text] [Related]

  • 9. The effects of sorbinil, an aldose reductase inhibitor, on the corneal endothelium in galactosemic dogs.
    Datiles MB, Kador PF, Kashima K, Kinoshita JH, Sinha A.
    Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2201-4. PubMed ID: 2122961
    [Abstract] [Full Text] [Related]

  • 10. Modulation of myo-[3H]inositol uptake by glucose and sorbitol in cultured bovine lens epithelial cells. I. Restoration of myo-inositol uptake by aldose reductase inhibition.
    Cammarata PR, Chen HQ, Yang J, Yorio T.
    Invest Ophthalmol Vis Sci; 1992 Dec; 33(13):3561-71. PubMed ID: 1464502
    [Abstract] [Full Text] [Related]

  • 11. CP-45,634: a novel aldose reductase inhibitor that inhibits polyol pathway activity in diabetic and galactosemic rats.
    Peterson MJ, Sarges R, Aldinger CE, MacDonald DP.
    Metabolism; 1979 Apr; 28(4 Suppl 1):456-61. PubMed ID: 122297
    [Abstract] [Full Text] [Related]

  • 12. Sorbitol, myo-inositol, and rod outer segment phagocytosis in cultured hRPE cells exposed to glucose. In vitro model of myo-inositol depletion hypothesis of diabetic complications.
    Del Monte MA, Rabbani R, Diaz TC, Lattimer SA, Nakamura J, Brennan MC, Greene DA.
    Diabetes; 1991 Oct; 40(10):1335-45. PubMed ID: 1936595
    [Abstract] [Full Text] [Related]

  • 13. Glomerular polyol accumulation in diabetes and its prevention by oral sorbinil.
    Beyer-Mears A, Ku L, Cohen MP.
    Diabetes; 1984 Jun; 33(6):604-7. PubMed ID: 6427041
    [Abstract] [Full Text] [Related]

  • 14. The prevention of biochemical changes in lens, retina, and nerve of galactosemic dogs by the aldose reductase inhibitor AL01576.
    Lou MF, Dickerson JE, Chandler ML, Brazzell RK, York BM.
    J Ocul Pharmacol; 1989 Jun; 5(3):233-40. PubMed ID: 2516529
    [Abstract] [Full Text] [Related]

  • 15. Normalization of lens protein kinase Cgamma in galactosemic dogs by a novel aldose reductase inhibitor.
    Takemoto DJ, Harris R, Brightman A, McGill J, Hua D, Davidson H, Fenwick B, Wagner LM.
    Vet Ophthalmol; 2004 Jun; 7(3):163-7. PubMed ID: 15091323
    [Abstract] [Full Text] [Related]

  • 16. Ultrastructural localization of blood-retinal barrier breakdown in diabetic and galactosemic rats.
    Vinores SA, McGehee R, Lee A, Gadegbeku C, Campochiaro PA.
    J Histochem Cytochem; 1990 Sep; 38(9):1341-52. PubMed ID: 2117624
    [Abstract] [Full Text] [Related]

  • 17. Prevention or moderation of some ultrastructural changes in the RPE and retina of galactosemic rats by aldose reductase inhibition.
    Vinores SA, Campochiaro PA.
    Exp Eye Res; 1989 Sep; 49(3):495-510. PubMed ID: 2507341
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of polyol pathway activity in diabetic and galactosemic rats by the aldose reductase inhibitor CP-45,634.
    Peterson MJ, Sarges R, Aldinger CE, MacDonald DP.
    Adv Exp Med Biol; 1979 Sep; 119():347-56. PubMed ID: 115231
    [No Abstract] [Full Text] [Related]

  • 19. Effect of galactose and glucose levels and sorbinil treatment on myo-inositol metabolism and Na+-K+ pump activity in cultured neuroblastoma cells.
    Yorek MA, Dunlap JA, Leeney EM.
    Diabetes; 1989 Aug; 38(8):996-1004. PubMed ID: 2546844
    [Abstract] [Full Text] [Related]

  • 20. Electron microscopic immunocytochemical evidence for the mechanism of blood-retinal barrier breakdown in galactosemic rats and its association with aldose reductase expression and inhibition.
    Vinores SA, Van Niel E, Swerdloff JL, Campochiaro PA.
    Exp Eye Res; 1993 Dec; 57(6):723-35. PubMed ID: 8150024
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.